tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Technical Analysis

Compare
8 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Ascletis Pharma, Inc.’s (1672) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting Ascletis Pharma, Inc. is a Buy.
Ascletis Pharma, Inc.’s (1672) 20-Day exponential moving average is 13.53, while Ascletis Pharma, Inc.’s (1672) share price is HK$13, making it a Sell.
Ascletis Pharma, Inc.’s (1672) 50-Day exponential moving average is 12.72, while Ascletis Pharma, Inc.’s (1672) share price is HK$13, making it a Buy.

Ascletis Pharma, Inc. (1672) Pivot Points

Dec 20, 2025, 07:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.54
11.98
12.31
12.75
13.08
13.52
13.85
Fibonacci
11.98
12.28
12.46
12.75
13.05
13.23
13.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascletis Pharma, Inc. (1672) Moving Averages

Dec 20, 2025, 07:27 PM
Period
Simple
Exponential
MA5
12.93Buy
13.18Sell
MA10
14.13Sell
13.54Sell
MA20
14.01Sell
13.53Sell
MA50
11.91Buy
12.72Buy
MA100
12.27Buy
11.81Buy
MA200
10.08Buy
9.78Buy
Ascletis Pharma, Inc.’s (1672) 10-Day exponential moving average is 13.54, while Ascletis Pharma, Inc.’s (1672) share price is HK$13, making it a Sell.
Ascletis Pharma, Inc.’s (1672) 100-Day exponential moving average is 11.81, while Ascletis Pharma, Inc.’s (1672) share price is HK$13, making it a Buy.
Ascletis Pharma, Inc.’s (1672) stock price is HK$13 and Ascletis Pharma, Inc.’s (1672) 50-day simple moving average is 11.91, creating a Buy signal.
Ascletis Pharma, Inc.’s (1672) stock price is HK$13 and Ascletis Pharma, Inc.’s (1672) 100-day simple moving average is 12.27, creating a Buy signal.
Ascletis Pharma, Inc.’s (1672) stock price is HK$13 and Ascletis Pharma, Inc.’s (1672) 200-day simple moving average is 10.08, creating a Buy signal.

Ascletis Pharma, Inc. (1672) Technical Indicators

Dec 20, 2025, 07:27 PM
Name
Value
Implied Action
RSI (14)
48.12
Neutral
STOCH (9,6)
9.42
Buy
STOCHRSI (14)
20.33
Neutral
MACD (12,26)
0.24
Buy
ADX (14)
18.31
Buy
Williams %R
-78.36
Buy
CCI (14)
-90.11
Neutral
ATR (14)
1.09
-
Ultimate Oscillator
38.71
Neutral
ROC
-10.59
Sell
Ascletis Pharma, Inc.’s (1672) Relative Strength Index (RSI) is 48.12, creating a Neutral signal.
Ascletis Pharma, Inc.’s (1672) Trend Strength Indicator (ADX) is 18.31, creating a Buy signal.
Ascletis Pharma, Inc.’s (1672) Commodity Channel Index (CCI) is -90.11, creating a Neutral signal.
Ascletis Pharma, Inc.’s (1672) Price Rate of Change (ROC) is -10.59, creating a Sell signal.

FAQ

Is 1672 a Buy, Hold, or Sell?
Based on 1672’s technical indicators, 1672 is a Buy.
    What is 1672’s RSI (14)?
    1672’s RSI (14) is 48.12, which suggests 1672 is a Neutral.
      What is 1672’s MACD?
      1672’s MACD is 0.24, which suggests 1672 is a Buy.
        What is 1672’s 5-day moving average?
        1672’s 5-day moving average is 12.93, which suggests 1672 is a Buy.
          What is 1672’s 20-day moving average?
          1672 20-day moving average is 14.01, which suggests 1672 is a Sell.
            What is 1672’s 50-day moving average?
            1672’s 50-day moving average is 11.91, which suggests 1672 is a Buy.
              What is 1672’s 200-day moving average?
              1672’s 200-day moving average is 10.08, which suggests 1672 is a Buy.
                What is 1672’s Williams % R (14)?
                1672’s Williams % R (14) is -78.36, which suggests 1672 is a Buy.
                  What is 1672’s CCI (14)?
                  1672’s CCI (14) is -90.11, which suggests 1672 is a Neutral.
                    What is the share price of Ascletis Pharma, Inc.?